Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Therapeutic Advances in Medical Oncology|March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.Journal of Cancer Research and Clinical Oncology|May 2, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapyAmina Maimaitiaili, Heyan Chen, Peiling Xie, et al.Frontiers in Oncology|May 27, 2024
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)Amina Maimaitiaili, Yijun Li, Na Chai, et al.Nature Medicine|November 5, 2021
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trialBinghe Xu, Qingyuan Zhang, Pin Zhang, et al.Breast (Edinburgh, Scotland)|January 26, 2024
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?Xuhui Guo, Jiao Zhang, Xilong Gong, et al.Eclinicalmedicine|September 29, 2020
Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020Jianbin Li, Haibo Wang, Cuizhi Geng, et al.JAMA Oncology|June 1, 2026
Fovinaciclib for First-Line Therapy of Advanced Breast Cancer: A Randomized Clinical TrialPeng Yuan, Yunjiang Liu, Wei Li, et al.Frontiers in Oncology|April 2, 2021
Assessment of CPS + EG, Neo-Bioscore and Modified Neo-Bioscore in Breast Cancer Patients Treated With Preoperative Systemic Therapy: A Multicenter Cohort StudyLing Xu, Yinhua Liu, Zhimin Fan, et al.JAMA|December 13, 2024
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical TrialLi Chen, Hui Li, Hao Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III TrialJunjie Li, Keda Yu, Da Pang, et al.Pageof 10